<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">01763</article-id><article-id pub-id-type="doi">10.7554/eLife.01763</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-2022"><name><surname>Wang</surname><given-names>Yubao</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8707"><name><surname>Lee</surname><given-names>Young-Mi</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8713"><name><surname>Baitsch</surname><given-names>Lukas</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8756"><name><surname>Huang</surname><given-names>Alan</given-names></name><aff><institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8758"><name><surname>Xiang</surname><given-names>Yi</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13651"><name><surname>Tong</surname><given-names>Haoxuan</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13649"><name><surname>Lako</surname><given-names>Ana</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13650"><name><surname>Von</surname><given-names>Thanh</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8757"><name><surname>Choi</surname><given-names>Christine</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8717"><name><surname>Lim</surname><given-names>Elgene</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Oncology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8709"><name><surname>Min</surname><given-names>Junxia</given-names></name><aff><institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8710"><name><surname>Li</surname><given-names>Li</given-names></name><aff><institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8714"><name><surname>Stegmeier</surname><given-names>Frank</given-names></name><aff><institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8715"><name><surname>Schlegel</surname><given-names>Robert</given-names></name><aff><institution>Novartis Institutes for Biomedical Research</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13648"><name><surname>Eck</surname><given-names>Michael J</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4531"><name><surname>Gray</surname><given-names>Nathanael S</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-8716"><name><surname>Mitchison</surname><given-names>Timothy J</given-names></name><aff><addr-line><named-content content-type="department">Department of Systems Biology</named-content></addr-line>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8531"><name><surname>Zhao</surname><given-names>Jean J</given-names></name><aff><addr-line><named-content content-type="department">Department of Cancer Biology</named-content></addr-line>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country><email>jean_zhao@dfci.harvard.edu</email></aff><xref ref-type="fn" rid="conf2"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1187"><name><surname>Staudt</surname><given-names>Louis</given-names></name><role>Reviewing editor</role><aff><institution>National Cancer Institute</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e01763</elocation-id><supplementary-material><ext-link xlink:href="elife-01763-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>23</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>05</month><year>2014</year></date></history><permissions><copyright-statement>Copyright Â© 2014, Wang et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Wang et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Despite marked advances in breast cancer therapy, basal-like breast cancer (BBC), an aggressive subtype of breast cancer usually lacking estrogen and progesterone receptors, remains difficult to treat. Here, we report the identification of MELK as a novel oncogenic kinase from an in vivo tumorigenesis screen using a kinome-wide open reading frames (ORFs) library. Analysis of clinical data reveals a high level of MELK overexpression in BBC, a feature that is largely dependent on FoxM1, a master mitotic transcription factor that is also found to be highly overexpressed in BBC. Ablation of MELK selectively impairs proliferation of basal-like, but not luminal breast cancer cells both in vitro and in vivo. Mechanistically, depletion of MELK in BBC cells induces caspase-dependent cell death, preceded by defective mitosis. Finally, we find that Melk is not required for mouse development and physiology. Together, these data indicate that MELK is a normally non-essential kinase, but is critical for BBC and thus represents a promising selective therapeutic target for the most aggressive subtype of breast cancer.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jean J Zhao, YW, YL, AH, JZ are inventors on a patent based on some of the work described here. AH, JM, LL, RS, FS are employees of Novartis Pharmaceuticals. The other authors declare that no competing interests.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was conducted in accordance with the animal use guidelines from the National Institutes of Health and with protocols (#02-127, #06-034) approved by the Dana-Farber Cancer Institute Animal Care and Use Committee.</p></fn></fn-group></back></article>